
|Podcasts|June 30, 2021
Manufacturing Cell Therapies with an Individualized Mindset
Author(s)Catalent
Cell therapy market has been experiencing double digit growth in recent years stemming from the promising success of the first autologous CAR-T products. However, manufacturing these therapies at scale continues to be a challenge. This podcast will focus on the specialized needs of manufacturing cell therapies at scale and how Custom Manufacturing Organizations are stepping in to drive process efficiencies and standardization.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
2
Charles River Incubator Cohort to Accelerate CGT Development
3
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
4
Developing Next-Gen Cell Lines Using Targeted Integration
5





